BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34974568)

  • 1. Clinical Outcome of paediatric ewing sarcoma and significance of pathological necrosis for mortality after neoadjuvant chemotherapy: Single institutional study.
    Sindhu II; Mehreen A; Wali RM; Abubakar M
    J Pak Med Assoc; 2021 Oct; 71(10):2344-2349. PubMed ID: 34974568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.
    Wunder JS; Paulian G; Huvos AG; Heller G; Meyers PA; Healey JH
    J Bone Joint Surg Am; 1998 Jul; 80(7):1020-33. PubMed ID: 9698007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
    Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcoma.
    Halalsheh H; Kaste SC; Krasin MJ; Sykes A; Sahr N; Spunt SL; Federico SM; Bishop MW
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28150. PubMed ID: 31944574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma.
    Lozano-Calderón SA; Albergo JI; Groot OQ; Merchan NA; El Abiad JM; Salinas V; Gomez Mier LC; Montoya CS; Ferrone ML; Ready JE; Linares FJ; Levin AS; Peleteiro Pensado M; Pozo Kreilinger JJ; Ruiz IB; Ortiz-Cruz EJ; Gebhardt MC; Cote GM; Choy E; Spentzos D; Hung YP; Deshpande V; Chebib IA; McCulloch RA; Farfalli G; Aponte Tinao L; Morris CD; Petur Nielsen G; Anderson ME; Jeys LM
    Cancer; 2023 Jan; 129(1):60-70. PubMed ID: 36305090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ewing sarcoma of the hand or foot.
    Froeb D; Ranft A; Boelling T; Paulussen M; Klco-Brosius S; Jürgens H; Dirksen U
    Klin Padiatr; 2012 Oct; 224(6):348-52. PubMed ID: 23143762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1.
    Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL;
    BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.
    Albergo JI; Gaston CL; Laitinen M; Darbyshire A; Jeys LM; Sumathi V; Parry M; Peake D; Carter SR; Tillman R; Abudu AT; Grimer RJ
    Bone Joint J; 2016 Aug; 98-B(8):1138-44. PubMed ID: 27482030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes with nondose-dense chemotherapy for Ewing sarcoma: A practical approach for the developing world.
    Parambil BC; Vora T; Sankaran H; Prasad M; Bakshi A; Puri A; Gulia A; Qureshi S; Laskar S; Khanna N; Shah S; Ramadwar M; Kembhavi S; Chinnaswamy G; Banavali S
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28604. PubMed ID: 32706522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraskeletal Ewing sarcomas in late adolescence and adults: a study of 37 patients.
    Tao HT; Hu Y; Wang JL; Cheng Y; Zhang X; Wang H; Zhang SJ
    Asian Pac J Cancer Prev; 2013; 14(5):2967-71. PubMed ID: 23803063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous and subcutaneous Ewing sarcoma.
    Di Giannatale A; Frezza AM; Le Deley MC; Marec-Bérard P; Benson C; Blay JY; Bui B; Judson I; Oberlin O; Whelan J; Gaspar N
    Pediatr Blood Cancer; 2015 Sep; 62(9):1555-61. PubMed ID: 25894676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group.
    Foulon S; Brennan B; Gaspar N; Dirksen U; Jeys L; Cassoni A; Claude L; Seddon B; Marec-Berard P; Whelan J; Paulussen M; Streitbuerger A; Oberlin O; Juergens H; Grimer R; Le Deley MC
    Eur J Cancer; 2016 Jul; 61():128-36. PubMed ID: 27176931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraosseous Ewing sarcoma in children and adolescents: A retrospective series from a referral pediatric oncology center.
    Livellara V; Bergamaschi L; Puma N; Chiaravalli S; Podda M; Casanova M; Gasparini P; Pecori E; Alessandro O; Nigro O; Sironi G; Gattuso G; Terenziani M; Spreafico F; Meazza C; Biassoni V; Schiavello E; Massimino M; Luksch R; Ferrari A
    Pediatr Blood Cancer; 2022 May; 69(5):e29512. PubMed ID: 34962687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
    Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology.
    Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S
    Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.
    Vijayasekharan K; Ramanathan S; Chinnaswamy G; Prasad M; Gulia A; Janu A; Rekhi B; Ramadwar M; Khanna N; Laskar S; Puranadare N; Bajpai J; Puri A; Banavali S; Vora T
    J Adolesc Young Adult Oncol; 2021 Apr; 10(2):185-192. PubMed ID: 32706630
    [No Abstract]   [Full Text] [Related]  

  • 18. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease.
    Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN
    Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS-81, -86, -91, -96, and -2002P trials.
    Seitz G; Urla C; Sparber-Sauer M; Schuck A; Vokuhl C; Blank B; Klingebiel T; Kazanowska B; Fuchs J; Koscielniak E
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27537. PubMed ID: 30421578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and prognostic factors for Ewing-family tumors of the extremities.
    Biswas B; Rastogi S; Khan SA; Mohanti BK; Sharma DN; Sharma MC; Mridha AR; Bakhshi S
    J Bone Joint Surg Am; 2014 May; 96(10):841-9. PubMed ID: 24875025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.